Hot Investor Mandate: Europe Fund Invests Early in Therapeutics, Diagnostics and Agtech

5 Dec

A venture capital firm based in the Benelux region is focused on identifying and investing in promising European companies. The firm generally invests from the very early stages from Seed to Series A and often acts as the first institutional investor, but also reserves 1/3 of the fund to more late-stage opportunities as well. The firm could invest as little as $200K or up to $3M in a first investment round, depending on the company’s current stage of development. The firm seeks to invest in companies that have a presence in Europe.

The firm invests broadly across therapeutics, diagnostics, and agriculture, but does not invest in medical devices, healthcare IT, or bioinformatics. The is open to all different types of technologies and indications.

The firm can act as either a lead or co-investor. In cases where the firm acts as the first institutional investor, the firm will seek board representation and take an active role in helping the company grow.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: